See HealthCap’s activity on LinkedIn

HealthCap reposted this

Co-Founder & Chief Scientific Officer, Carisma Therapeutics

4mo

We are thrilled to announce the first Development Candidate under the collaboration between Carisma Therapeutics and Moderna - an in vivo CAR-M targeting Glypican-3 (GPC3) to treat hepatocellular carcinoma. More info here: https://lnkd.in/gyeRZMqZ

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

prnewswire.com

20 Comments

B₊labs

4mo

Congrats to the Carisma Therapeutics and Moderna teams here. Looking forward to watching this progress.

Souad Amiar, PhD

Interdisciplinary scientist seeking to help grow innovative technologies in life sciences.

4mo

Very exciting! Can't wait to hear more about the fruits of this collaboration!

Frank Metzel

Get more (and better) investor meetings with animations that explain your science | CEO and Founder | 300+ animations produced

4mo

I hope you will succeed with your in vivo CAR-M therapies and fight HCC Michael Klichinsky. Congrats!

Bin Xu

Inventor in Nucleic Acid-based Diagnostics | SME in Analytical Genomics I Expertise in Bioanalytics of Gene and Cell Therapy | Strong Business Acumen

4mo

Moving forward!

Tatiana Novobrantseva

Inventing and developing new medicines, building teams.

3mo

Great to see this going forward!

Karim Shalaby

Research Associate at University of Waterloo, School of Pharmacy | Development of Therapeutic Antibodies

4mo

That's fantastic Michael! Congratulations to you and the team!! 👏🏻👏🏻👏🏻

Atrish Bagchi, Ph.D.

Protein Engineer and Structural Biologist Developing Antibody Therapies

4mo

Great news! Congratulations to the team.

Rachel Temple

Key Account Executive, Immunology at STEMCELL Technologies - Scientist Helping Scientist

4mo

This is so exciting! Good luck!

Ngoc ‘Emily’ Le

Associate Director, Business Development, Commercialization, Strategy, Innovation

4mo

Great news Michael! Looking forward to hearing more about the results!

HealthCap’s Post

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

prnewswire.com

Explore topics